Related Experiment Video
Updated: Mar 13, 2026
08:23
Single Cell Transcriptional Profiling of Adult Mouse Cardiomyocytes
Published on: December 28, 2011
18.2K
Analyzing gene expression profiles in dilated cardiomyopathy via bioinformatics methods.
Liming Wang1, L Zhu2, R Luan3
1Emergency Department, The Second Affiliated Hospital of Xi'an, Jiaotong University, Xi'an, China.
Summary
This study identified key genes, transcription factors, and microRNAs involved in dilated cardiomyopathy (DCM) using bioinformatics. These findings may lead to new diagnostic markers and therapeutic strategies for DCM.
Area of Science:
- Genomics
- Cardiovascular Biology
- Bioinformatics
Background:
- Dilated cardiomyopathy (DCM) is a primary cause of heart failure and necessitates cardiac transplantation.
- Understanding the genetic underpinnings of DCM is crucial for developing effective treatments.
Purpose of the Study:
- To identify potential genes associated with DCM.
- To explore the regulatory mechanisms, including transcription factors (TFs) and microRNAs (miRNAs), involved in DCM pathogenesis.
- To discover potential small molecule drugs for DCM treatment.
Main Methods:
- Utilized bioinformatics to analyze gene expression profiles from the Gene Expression Omnibus (GEO) database (GSE3586).
- Identified differentially expressed genes (DEGs) between normal and DCM samples using the Limma package.
- Performed pathway enrichment analysis and predicted TFs, miRNAs, and small molecule drugs using databases like cMap.
Main Results:
- Identified 4777 DEGs between DCM and control samples.
- DEGs were significantly enriched in pathways including lymphocyte TarBase and androgen receptor signaling.
- Identified potential TFs (SP1, LEF1, NFAT), miRNAs (miR-9, miR-200 family, miR-30 family), and small molecules (isoflupredone, trihexyphenidyl).
Conclusions:
- The identified DEGs (e.g., PRSS12, FOXG1), TFs, and miRNAs are potentially implicated in the development of DCM.
- Bioinformatic analysis provides insights into DCM's molecular mechanisms and suggests potential therapeutic avenues.
